Grail (GRAL) Competitors $31.22 -0.91 (-2.82%) As of 02:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. RDNT, SHC, SGRY, BTSG, PRVA, CON, WGS, LFST, VCYT, and ARDTShould you be buying Grail stock or one of its competitors? The main competitors of Grail include RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), LifeStance Health Group (LFST), Veracyte (VCYT), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry. Grail vs. RadNet Sotera Health Surgery Partners BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent GeneDx LifeStance Health Group Veracyte Ardent Health Partners Grail (NASDAQ:GRAL) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, community ranking, institutional ownership, dividends, analyst recommendations, risk and earnings. Which has stronger valuation and earnings, GRAL or RDNT? RadNet has higher revenue and earnings than Grail. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGrail$125.60M8.67N/AN/AN/ARadNet$1.83B2.10$3.04M$0.031,727.67 Do analysts recommend GRAL or RDNT? Grail presently has a consensus target price of $20.00, indicating a potential downside of 37.75%. RadNet has a consensus target price of $73.25, indicating a potential upside of 41.33%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Grail 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Does the media favor GRAL or RDNT? In the previous week, RadNet had 12 more articles in the media than Grail. MarketBeat recorded 21 mentions for RadNet and 9 mentions for Grail. Grail's average media sentiment score of 1.07 beat RadNet's score of 0.81 indicating that Grail is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Grail 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 10 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in GRAL or RDNT? 77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor GRAL or RDNT? RadNet received 355 more outperform votes than Grail when rated by MarketBeat users. Likewise, 66.23% of users gave RadNet an outperform vote while only 0.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformGrailOutperform VotesNo VotesUnderperform Votes4100.00% RadNetOutperform Votes35566.23% Underperform Votes18133.77% Is GRAL or RDNT more profitable? Grail has a net margin of 0.00% compared to RadNet's net margin of -0.25%. RadNet's return on equity of 4.29% beat Grail's return on equity.Company Net Margins Return on Equity Return on Assets GrailN/A N/A N/A RadNet -0.25%4.29%1.45% SummaryRadNet beats Grail on 12 of the 15 factors compared between the two stocks. Remove Ads Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGrailMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.09B$2.96B$5.74B$8.28BDividend YieldN/A21.70%4.55%4.02%P/E RatioN/A13.6524.7419.36Price / Sales8.67217.08393.1193.27Price / CashN/A57.5638.1634.64Price / BookN/A4.767.164.51Net IncomeN/A-$22.21M$3.20B$247.14M7 Day Performance14.02%3.49%2.86%3.64%1 Month Performance-25.47%-2.34%7.01%-2.30%1 Year PerformanceN/A7.75%15.61%4.93% Grail Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGrail0.9886 of 5 stars$31.34-2.5%$20.00-36.2%N/A$1.06B$125.60M0.001,360Positive NewsRDNTRadNet4.2678 of 5 stars$49.02+5.3%$76.75+56.6%+7.9%$3.63B$1.83B-700.198,970Analyst ForecastNews CoverageHigh Trading VolumeSHCSotera Health2.7775 of 5 stars$11.93+2.9%$15.92+33.4%+8.1%$3.38B$1.10B47.723,000SGRYSurgery Partners2.8628 of 5 stars$24.40+3.4%$36.63+50.1%-12.3%$3.11B$3.11B-50.8313,500Analyst ForecastPositive NewsBTSGBrightSpring Health Services2.2226 of 5 stars$17.45+0.2%$21.67+24.2%+94.5%$3.05B$11.27B-67.1235,000PRVAPrivia Health Group3.7684 of 5 stars$23.24-2.1%$26.67+14.7%+22.0%$2.80B$1.74B232.421,102CONConcentra Group Holdings ParentN/A$21.04+1.2%$28.38+34.8%N/A$2.68B$1.90B13.9411,000News CoveragePositive NewsWGSGeneDx2.2553 of 5 stars$94.46-4.1%$72.33-23.4%+1,098.5%$2.65B$305.45M-48.191,200Positive NewsLFSTLifeStance Health Group2.3945 of 5 stars$6.89-0.4%$8.63+25.2%+14.0%$2.65B$1.25B-26.509,325VCYTVeracyte4.0272 of 5 stars$31.23-0.9%$43.00+37.7%+57.2%$2.43B$445.76M-208.20790ARDTArdent Health PartnersN/A$14.02+0.9%$21.18+51.1%N/A$2.00B$5.97B0.0024,200 Remove Ads Related Companies and Tools Related Companies RadNet Alternatives Sotera Health Alternatives Surgery Partners Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives GeneDx Alternatives LifeStance Health Group Alternatives Veracyte Alternatives Ardent Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
